Dr Claude Vaislic

Introduction Outcomes are now available out to 4 years for the prospective nonrandomized STRATO trial. Th is 10-center French study was undertaken between April 2010 and February 2011 in order to assess the effi cacy, safety, and performance of the…

Vaislic C. and al Abstract Purpose: To evaluate midterm outcomes of endovascular repair of types II and III thoracoabdominal aortic aneurysms (TAAA) using the Multilayer Flow Modulator (MFM) in patients unsuitable for open surgery or fenestrated stent-grafts. Methods: In the…

Vola M, Campisi S, Anselmi A, Vaislic C, Fuzellier JF. Abstract BACKGROUND AND AIM OF THE STUDY: Transcatheter aortic valve implantation (TAVI) is a promising option to treat degenerated aortic valve bioprostheses, and may involve Valve-in-Valve (ViV) procedures. Unfortunately, the…

E. Ramiaramanana, S. Taamalah, N. Rabah, A Al Karaky, Imen Benhadj and C. Vaislic* Keywords Cardiovascular surgery; Blood conservation; Multidisciplinary approach; Jehovah’s witnesses; Perioperative outcomes Background Cardiovascular surgery in patients who are Jehovah’s Witnesses (JW) poses both technical and ethical…

C. VAISLIC, A. BENJELLOUN, J.-N. FABIANI, J.-F. BONNEVILLE, S. CHOCRON Abstract Current treatment of thoracoabdominal aneurysms is associated with significant morbidity and mortality. The most feared and devastating complication is paraplegia accompanied by sphincter and posture problems. To try and…

Case report – Vascular thoracic 3 / Multilayer stents in the treatment of thoraco-abdominal residual type B dissection Sidney Chocrona,*, Claude Vaislicb, Djamel Kailia, Jean-Francois Bonnevillec. Department of Thoracic and Cardiovascular Surgery, Jean Minjoz Hospital, F-25030 Besancon, France CMC Parly…

Thoracoabdominal aneurysms pose a public health problem that is underestimated in the medical press. Their prevalence can be deduced from a Swedish study conducted between 1958 and 1985 in a stable urban population with high autopsy rates. They are evaluated…

Conclusion : Following cardiac surgery, emergent PCI revascularization are low-incidence cardiac events but yield high level of complications due to the high-risk cardiac profile of the patients in this setting (STEMI and cardiogenic shock). After non-CABG cardiac surgery, acute ischemia…

Report From the STRATO Trial Claude D. Vaislic, MD1; Jean Noel Fabiani, MD, PhD2; Sidney Chocron, MD, PhD3; Jacques Robin, MD4; Victor S. Costache, MD5; Jean-Pierre Villemot, MD, PhD6; Jean Marc Alsac, MD2; Pascal N. Leprince, MD, PhD7; Thierry Unterseeh,…

Mickael Vaislic 1; Claude Vaislic 2,*; Jean-Marc Alsac 3; Amira Benjelloun 4; Sidney Chocron 5; Thierry Unterseeh 6; Jean-Noel Fabiani 7 1. European Company of Strategic Intelligence, Paris, France 2. Cardiovascular Surgery, Parly II Private Hospital, Le Chesnay, France 3.…